BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28812537)

  • 1. Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease cases.
    Krämer A; Shah S; Rebres RA; Tang S; Richards DR
    BMC Genomics; 2017 Aug; 18(Suppl 5):551. PubMed ID: 28812537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes.
    Roca I; Fernández-Marmiesse A; Gouveia S; Segovia M; Couce ML
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29861492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GeneYenta: a phenotype-based rare disease case matching tool based on online dating algorithms for the acceleration of exome interpretation.
    Gottlieb MM; Arenillas DJ; Maithripala S; Maurer ZD; Tarailo Graovac M; Armstrong L; Patel M; van Karnebeek C; Wasserman WW
    Hum Mutat; 2015 Apr; 36(4):432-8. PubMed ID: 25703386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
    Seaby EG; Ennis S
    Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VarSight: prioritizing clinically reported variants with binary classification algorithms.
    Holt JM; Wilk B; Birch CL; Brown DM; Gajapathy M; Moss AC; Sosonkina N; Wilk MA; Anderson JA; Harris JM; Kelly JM; Shaterferdosian F; Uno-Antonison AE; Weborg A; ; Worthey EA
    BMC Bioinformatics; 2019 Oct; 20(1):496. PubMed ID: 31615419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite.
    Stelzer G; Plaschkes I; Oz-Levi D; Alkelai A; Olender T; Zimmerman S; Twik M; Belinky F; Fishilevich S; Nudel R; Guan-Golan Y; Warshawsky D; Dahary D; Kohn A; Mazor Y; Kaplan S; Iny Stein T; Baris HN; Rappaport N; Safran M; Lancet D
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):444. PubMed ID: 27357693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xrare: a machine learning method jointly modeling phenotypes and genetic evidence for rare disease diagnosis.
    Li Q; Zhao K; Bustamante CD; Ma X; Wong WH
    Genet Med; 2019 Sep; 21(9):2126-2134. PubMed ID: 30675030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases.
    De La Vega FM; Chowdhury S; Moore B; Frise E; McCarthy J; Hernandez EJ; Wong T; James K; Guidugli L; Agrawal PB; Genetti CA; Brownstein CA; Beggs AH; Löscher BS; Franke A; Boone B; Levy SE; Õunap K; Pajusalu S; Huentelman M; Ramsey K; Naymik M; Narayanan V; Veeraraghavan N; Billings P; Reese MG; Yandell M; Kingsmore SF
    Genome Med; 2021 Oct; 13(1):153. PubMed ID: 34645491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical guide to filtering and prioritizing genetic variants.
    Jalali Sefid Dashti M; Gamieldien J
    Biotechniques; 2017 Jan; 62(1):18-30. PubMed ID: 28118812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project.
    Stenton SL; O'Leary MC; Lemire G; VanNoy GE; DiTroia S; Ganesh VS; Groopman E; O'Heir E; Mangilog B; Osei-Owusu I; Pais LS; Serrano J; Singer-Berk M; Weisburd B; Wilson MW; Austin-Tse C; Abdelhakim M; Althagafi A; Babbi G; Bellazzi R; Bovo S; Carta MG; Casadio R; Coenen PJ; De Paoli F; Floris M; Gajapathy M; Hoehndorf R; Jacobsen JOB; Joseph T; Kamandula A; Katsonis P; Kint C; Lichtarge O; Limongelli I; Lu Y; Magni P; Mamidi TKK; Martelli PL; Mulargia M; Nicora G; Nykamp K; Pejaver V; Peng Y; Pham THC; Podda MS; Rao A; Rizzo E; Saipradeep VG; Savojardo C; Schols P; Shen Y; Sivadasan N; Smedley D; Soru D; Srinivasan R; Sun Y; Sunderam U; Tan W; Tiwari N; Wang X; Wang Y; Williams A; Worthey EA; Yin R; You Y; Zeiberg D; Zucca S; Bakolitsa C; Brenner SE; Fullerton SM; Radivojac P; Rehm HL; O'Donnell-Luria A
    Hum Genomics; 2024 Apr; 18(1):44. PubMed ID: 38685113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
    Bacchelli C; Williams HJ
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics.
    Bosio M; Drechsel O; Rahman R; Muyas F; Rabionet R; Bezdan D; Domenech Salgado L; Hor H; Schott JJ; Munell F; Colobran R; Macaya A; Estivill X; Ossowski S
    Hum Mutat; 2019 Jul; 40(7):865-878. PubMed ID: 31026367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges.
    Barbitoff YA; Ushakov MO; Lazareva TE; Nasykhova YA; Glotov AS; Predeus AV
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38271481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
    Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
    J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cruxome: a powerful tool for annotating, interpreting and reporting genetic variants.
    Han Q; Yang Y; Wu S; Liao Y; Zhang S; Liang H; Cram DS; Zhang Y
    BMC Genomics; 2021 Jun; 22(1):407. PubMed ID: 34082700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome sequencing data analysis for rare disease gene discovery.
    Umlai UI; Bangarusamy DK; Estivill X; Jithesh PV
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34498682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Exome Sequencing to Identify Rare Genetic Diseases.
    Udupa P; Ghosh DK
    Methods Mol Biol; 2024; 2719():79-98. PubMed ID: 37803113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.